Search

Obesity and metabolic syndrome (MetS) are growing problems among children and adolescents. There are no reports of changes in the activity of butyrylcholinesterase (BChE) in children and adolescents with metabolic syndrome especially after supplementation with extract from Aronia melanocarpa. Materials studied included plasma and erythrocytes isolated from peripheral blood of patients with MetS and healthy subjects. We have estimated the following parameters: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activity, lipid peroxidation and lipids levels in plasma, and erythrocytes membrane. In patients with MetS, a significant increase in AChE and BChE activity, higher LDL-cholesterol and triacylglycerol levels, and lower HDL-cholesterol level were observed. Supplementation with A. melanocarpa extract resulted in mild but statistically significant reduction of total cholesterol, LDL-cholesterol, and triacylglycerol levels and caused an increase in HDL-cholesterol level and a decrease in lipid peroxidation in plasma patients with MetS. Additionally, a decrease in lipid peroxidation and cholesterol level and a decrease in AChE activity in the erythrocyte membranes after supplementation with A. melanocarpa were noted. Summarizing, an increase in AChE and BChE activity and disruption of lipid metabolism in patients with MetS were observed. After supplementation of MetS patients with A. melanocarpa extract, a decrease in AChE activity and oxidative stress was noted. [ABSTRACT FROM AUTHOR]

Copyright of Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej is the property of Sciendo and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The aim of the study was to compare the effects in vitro of pravastatin and epicatechin on the structural parameters of erythrocyte membrane in patients with type-2 hypercholesterolemia. Material and methods. The study involved 20 patients with type-2 hypercholesterolemia (mean age 46±14). The control group consisted of 15 healthy individuals (mean age 48±10). Erythrocytes obtained from patients and healthy individuals were incubated with pravastutin (concentrations: 9µM, 90µM) and epicatechin (concentrations: 5µM, 10µM). In plasma membranes of erythrocytes we assessed the cholesterol content (by method of llcy), the level of TBARS (by method of Stocks and Dormandy) and the membrane fluidity by means of 5-DSA (paramagnetic resonance). Results. In erythrocytes of patients with hypercholesterolemia type-2 comparing to the control group significantly higher mean values of membrane cholesterol content (3,64±0,77 vs. 2.11±0,57 mmol/l pc), the order parameter S (0,748±0,011 vs. 0,770±0,013) and TBARS (1,48±0,47 vs. 3,40±0.75 mmol/g Hb) were observed. Phosphorus content in membrane phospholipids (I,73±0,34 vs. 2,51±0,8 mmol/1 pc) and molar ratio cholesterol/phospholipids (1,22±0,64 vs 1,45±0.25) were also higher in patients than in healthy volunteers. After incubation of erythrocytes with pravastatin and epicatechin the membrane fluidity at the depth of 5th carbon atom has improved, the membrane cholesterol concentration has decreased. Epicatechin influenced considerably the level of TBARS in comparison to pravastatin. Conclusions: 1) Epicatechin in vitro better decreases the membrane cholesterol content in patients with type-2 hypercholesterotemia than pravastatin. Both substances cause an increase in the fluidity of plasma membrane of erythrocytes. 2) Pravastatin, in vitro, in opposite to epicatechin does not influence on lipid peroxidation in erythrocytes of patients with type-2 hypercholesterolemia. [ABSTRACT FROM AUTHOR]

Unlabelled: Systemic sclerosis is a chronic connective tissue disease of unknown pathogenesis. In view of the reports of essential role of oxidative stress in development of disease, trials with supportive care with vitamin E are undertaken. The aim of the study was to estimate parameters of oxidation-reduction balance in erythrocytes from scleroderma patients, who were chronically treated with vitamin E compared with healthy controls., Material and Methods: In the study there were included 14 women with systemic sclerosis (limited form - ISSc - n = 10, diffuse form - dSsc - n = 4, age 53.8 lat +/- 11.5), who were treated with vitamin E in dose 400 mg/day not shorter than in 6 months period and 23 healthy women (age 52.7 +/- 11.2) as a control group. The following measurements were done: hs CRP (immunoturbidimetic method), glutathione peroxidase activity (Gpx--method of Rice-Evans, 1991), superoxide dismutase activity (SOD--method of Misra, 1972), catalase activity (CAT--method of Aebi H, 1984), free thiol group concentration (SH--method of ElIman, 1959), level of lipid peroxidation products (TBARs--method of Stocks and Dormandy, 1971), total antioxidant capacity (TAC) depended of slow (TAC "slow") and fast (TAC "fast") antioxidants., Results: . In both forms of systemic sclerosis significantly higher TBARs in comparison of healthy controls (5.81 +/- 1.57 vs 4.28 +/- 0.89 nM TBARS/gHb; p < 0.01) was observed. Patients with limited systemic sclerosis have significantly higher activity of Gpx (59.9 +/- 26.11 vs 32.19 +/- 11.67 U/mg Hb; p < 0.01), and no differences in activity of CAT and SOD. In patients with diffuse systemic sclerosis significantly lower activity of CAT (173.06 +/- 60.3 vs 284.47 +/- 43.33 U/mg Hb; p < 0.01) and SOD (2334.95 +/- 193.97 vs 3231.47 +/- 840.21 U/mg Hb; p < 0.05) was observed. There are no differences in TAC and SH between investigated groups., Conclusions: In scleroderma patients despite chronical treatment with vitamin E, oxidation-reduction balance disturbances are observed in the form of increased level of lipid peroxidation products. Besides, a lower activity of catalase and superoxide dysmutase in patients who suffer from diffuse form of systemic sclerosis is noted. Patients with limited systemic sclerosis have higher glutathione peroxidase activity.

Background: Experimental studies have shown that anthocyanins may exert pleiotropic effects. The aim of the study was to determine the influence of Aronia melanocarpa extract on blood pressure and serum concentration of endothelin-1 (ET-1), lipids, glucose, uric acid, C-reactive protein (CRP), fibrinogen, the antioxidant enzymes catalase (CAT), superoxide dysmutase (SOD), and glutathione peroxidase (GSH-Px), and lipid peroxidation (thiobarbituric acid-reacting substrates, TBARS) in erythrocytes of patients with metabolic syndrome (MS)., Material/methods: The study comprised 22 healthy volunteers and 25 patients with MS. Patients with MS were treated with aronia extract (3 x 100 mg/day) for two months. The above parameters were measured., Results: After two months of therapy, statistically significant decreases were observed in SBP (143.40+/-7.87 vs. 131.83+/-12.24 mmHg, p<0.001), DBP (87.20+/-9.9 vs. 82.13+/-10.33 mmHg, p<0.05), ET-1 (2.44+/-0.51 vs. 1.74+/-0.42 pg/ml, p<0.001), TC (242.80+/-34.48 vs. 227.96+/-33.07 mg/dl, p<0.001), LDL-C (158.71+/-35.78 vs. 146.21+/-34.63 mg/dl, p<0.01), TG (215.92+/-63.61 vs. 187.58+/-90 mg/dl, p<0.05), TBARS (0.0712+/-0.0191 vs. 0.0362+/-0.0135 micromol/g-Hb, p<0.001), and CAT (261.30+/-59.78 vs. 213.34+/-47.36 U/mg-Hb) and significant increases in SOD (2380.63+/-419.91 vs. 3066.53+/-542.24 U/g-Hb, p<0.001), GSH-Px (12.60+/-5.97 vs. 19.18+/-9.09 U/g-Hb, p<0.01), and fibrinogen levels (249.20+/-27.17 vs. 276.67+/-57.41 mg/dl, p<0.05) compared with the baseline values., Conclusions: Aronia extract may be of benefit to patients with MS. This seems to result from the influence of anthocyanins and possibly other flavonoids on blood pressure, serum level of ET-1, lipids, and oxidative status (GSH-Px, SOD, TBARS).

The Aim of the Study: To estimate the influence of anthocyanins from Aronia melanocarpa on blood pressure, concentration of endothelin-1 (ET-1), serum lipids, fasting glucose, uric acid and membrane cholesterol in erythrocytes of patients (pts) with metabolic syndrome (MS)., Material and Methods: The study comprised 22 healthy volunteers and 25 pts with MS treated with anthocyanins (3 x 100 mg/d) for 2 months. Waist circumference (> or = 80 cm for women and > or =94 cm for men), triglicerydes (TG) level >150 mg/dl (1.7 mmol/l), cholesterol-HDL (HDL-C) level < 40 mg/dl (1.0 mmol/l) for men and <50 mg/dl (1.3 mmol/l) for women, systolic blood pressure (SBP) >130 mmHg and/or diastolic blood pressure (DBP) >85 mmHg were inclusion criteria for patients with MS. Before and after 2 months of treatment the following parameters were determined: SBP, DBP, serum lipids (total cholesterol--TC, cholesterol LDL--LDL-C, cholesterol HDL--HDL-C, TG--by enzymatic method), membrane cholesterol in erythrocytes (method of IIcy), ET-1 (immunoenzymatic method), fasting glucose level was (colorimetric method), uric acid (enzymatic--colorimetric method)., Results: After two months therapy of anthocyanins from Aronia melanocarpa in comparison with baseline it was observed a significant decrease of: SBP (144.20 +/- 9.97 vs. 131.83 +/- 12.24 mmHg, p < 0.001) and DBP (87.20 +/- 9.9 vs. 82.13 +/- 10.33 mmHg, p < 0.05), TC (242.80 +/- 34.48 vs. 227.96 +/- 33.07 mg/dl, p < 0.001), LDL-C (158.71 +/- 35.78 vs. 146.21 +/- 34.63 mg/dl, p < 0.01), TG (215.92 +/- 63.61 vs. 187.58 +/- 90 mg/dl, p < 0.05), ET-1 (2.44 +/- 0.51 vs. 1.74 +/- 0.42 pg/ml, p < 0.001) and membrane cholesterol (4.85 +/- 0.65 vs. 2.81 +/- 0.54 mmol/Lpc, p < 0.001), uric acid and fasting blood glucose levels did not change significantly after study cessation., Conclusions: The results of our study show that anthocyanins from Aronia melanocarpa may be of benefit to patients with MS as for as atherosclerosis prevention is concerned. It seems to result from anthocyanins influence on blood pressure, serum lipid and endothelin-1 level.

Unlabelled: The aim of the study was to estimate the effects of 4-weeks therapy of fluvastatin extended release (XL) on lipids serum, C-reactive protein (CRP), erythrocyte structure membrane (thiobarbituric acid reactive substances--TBARS concentrations, membrane cholesterol and the activity of Na+K(+)-ATPase in erythrocytes) in patients with hyperlipidemia without any clinical signs of atherosclerosis., Material and Methods: The study comprised 37 persons, including 15 healthy volunteers and 22 patients with hyperlipidemia (TC > 200 mg/dl, LDL-C > 130 mg/dl, TG < 400 mg/dl) treated with fluvastatin XL 80 mg/d. Before and after 4 weeks of active treatment the following parameters were determined: lipids (by enzymatic method using BioMerieux tests), CRP (by immunoturbidimetric method), TBARS concentrations (by method of Stock and Dormandy), membrane cholesterol (method of Ilcy), Na+K(+)-ATPase activity (method of Bartosz et al.)., Results: It was noticed significantly higher concentrations of CRP, TBARS, membrane cholesterol and lower activity of Na+K(+)-ATPase in erythrocytes of patients with hyperlipidemia than in the control group. Fluvastatin XL caused a significant decrease in serum TC (by 18%), LDL-C (by 24%), TG (by 16%), CRP (by 23%) and TBARS (by 31%), membrane cholesterol (by 30%) in comparison to the initial values before active therapy. The activity of Na+K(+)-ATPase didn't significantly change. The mean values of CRP, TBARS, membrane cholesterol level after active treatment are still higher than in the control group., Conclusion: The short-term treatment of fluvastatin extended release wasn't enough efficient to compensate disorders in erythrocyte membrane structure of patients with hyperlipidemia.

Unlabelled: The aim of the study was to compare the effects in vitro of pravastatin and quercetin on the structural parameters of erythrocyte membrane of patients with hypercholesterolemia type II., Material and Method: 2% suspensions of erythrocytes from hypercholesterolemic patients (n = 30, mean age 54.2 +/- 6.9) and healthy donors (n = 22, mean age 53.1 +/- 6.1) were incubated for 24 hours at 37 degrees C with or without pravastatin (9 microM, 90 microM), quercetin (10 microM, 50 microM, 100 microM). After the incubation we assessed, the cholesterol content (by method of Ilcy), the level of TBARS (by method of Stocks and Dormandy), the membrane fluidity (by paramagnetic resonance)., Results: In erythrocytes of patients (pts) with hypercholesterolemia type II (hip II) in comparison to the control group significantly higher mean values of membrane cholesterol content (0.065 +/- 0.013 vs 0.039 +/- 0.008AU, p < 0.001), the order parameter S (0.775 +/- 0.018 vs 0.752 +/- 0.018, p < 0.001) and TBARS level (2.91 +/- 1.01 vs 1.60 +/- 0.41 mmol/gHb, p < 0.001) were observed. After incubation of erythrocytes from hypercholesterolemic patients with pravastatin it was noticed the significant decrease (in dependence on statin concentration - 9 microM, 90 microM) of mean cholesterol content (by 23% and 37%, respectively) and the order parameter S (by 2% and 3%) in comparison the values after erythrocyte incubation without statin. Pravastatin didn't influence on the level of TBARS. After incubation with quercetin it was observed the significant decrease of membrane cholesterol (26-33%), the order parameter S (maximum by 4%) i TBARS levels (16-25%)., Conclusions: 1. Pravastatin and quercetin, in vitro, in similar degree decrease the level of membrane cholesterol and advantageously influence on membrane fluidity of erythrocytes from patients with hypercholesterolemia type II. 2. Pravastatin, in vitro, in opposite to quercetin doesn't influence on lipid peroxidation in erythrocytes of patients with hypercholesterolemia type II and healthy.

In hypercholesterolemia the damage to the plasma membranes of erythrocytes is observed. This may result from higher concentration of cholesterol in plasma and membranes, lipids peroxidation and changes in protein conformation. The aim of the study was to estimate the membrane fluidity, concentration of cholesterol (Ch), phospholipids (PL), ratio of Ch/PL, thiobarbituric acid reaction substances (TBARS) in the isolated erythrocyte membrane of patients with mixed hyperlipidemia. The study comprised 50 patients in the age from 45 to 65 with the initial concentrations of total cholesterol (TC) > 200 mg/dl (5.2 mmol/l); cholesterol LDL (LDL-C) > 160 mg/dL (4.1 mmol/l); triglicerides (TG) > 150 mg/dL (4.5 mmol/L) and 22 healthy controls. The plasma lipids concentrations were determined by enzymatic method, the concentration of cholesterol membrane (by method of Ilcy), phospholipids (by method of Bartlett), lipids peroxidation (by method of Stocks and Dormandy) and the erythrocyte membrane fluidity (by a spin-label paramagnetic resonance method using 5-doxylstearic acid - 5-DSA, and 16-doxylstearic acid - 16-DSA). The order parameter S was determined using 5-DSA; 16-DSA was used to estimate the correlation taub and tauc. In group of patients with mixed hyperlipidemia in comparison to the control group it was noticed a significant increase of the mean values of order parameter S (0.74 +/- 0.01 vs. 0.72 +/- 0.005, p < 0.001), of membrane cholesterol concentration (3.39 +/-0.98 vs. 1.93 +/- 0.93 mmol/l pc, p < 0.001), ratio Ch/PL (2.32 +/- 1.22 vs. 1.22 +/- 0.44; p < 0,001) and TBARS (2.91 +/- 0.74 vs. 1.5 +/- 0.4 nmol/mg protein). The differences of the correlation times and phospholipids concentrations between the groups were not statistically significant. Significant correlation between the order parameter S and concentrations of TC, LDL-C in plasma and membrane cholesterol was observed. On the base of given results we conclude that mixed hyperlipidemia may have influence on the erythrocyte membrane structure caused significant decrease of membrane fluidity in the superficial layer without any significant changes in deeper layer and significant increase of membrane cholesterol and TBARS.

Unlabelled: In hyperlipidemia damage to the plasma membranes of erythrocytes is observed. It is supposed that statins by their beneficial impact on the serum lipids and pleiotropic effects may modify the membrane cell structure., Material and Methods: The aim of the study was to evaluate the effects of statins on erythrocyte membrane structure in patients (pts) with hyperlipidemia. The study involved 54 pts with the initial total cholesterol (TC) concentration > 200 mg/dl (6.5 mmol/l), low-density lipoprotein cholesterol (LDL-C) > 160 mg/dl (4.1 mmol/l) and triglycerides (TG) < 400 mg/dl (4.5 mmol/l) and 22 healthy individuals as the control group. After 8 weeks of hypolipemic diet, pts were randomized to two groups: A--27 pts treated with atorvastatin in a dose of 10 mg/day; S--27 pts treated with simvastatin in a dose of 40 mg/day. After 8 weeks of active therapy in all pts were determined: the activity of Na+K+-ATPase, erythrocyte membrane fluidity (the order parameter S), lipids peroxidation (thiobarbituric acid-reactive substances - TBARS), content of membrane cholesterol, concentration of SH groups and W/S ratio (which specifies the relations between the two kinds of the SH groups: the weakly--W bound, and the strongly--S bound)., Results: In the group of hyperlipidemic patients as compared to the control group we observed significantly higher values of the order parameter S, membrane cholesterol, TBARS, ratio W/S and significantly lower the activity of Na+K+-ATPase, SH groups concentration in membrane erythrocytes. Atorvastatin and simvastatin in a similar degree significantly increased the activity of Na'K'-ATPase (15.7% vs. 20.9%), the SH concentration groups (23.4% vs. 21.2%) and decreased TBARS (-41.8% vs. -41%), W/S ratio (-11.3% vs. S-12.1%). Simvastatin decreased stronger the membrane cholesterol (-30.0% vs. -24.5%; p < 0.05) and the values of parameter S (-5.1% vs. -3.5%, p < 0.05) than atorvastatin., Conclusions: A short-term therapy with statins exhibits a high hypolipemic efficacy and advantageous effects on the protein-lipid structure of erythrocyte membranes. Simvastatin at 40 mg/day dose increases the fluidity of erythrocyte membrane and decreases the membrane cholesterol level to a greater extent than does atorvastatin at 10 mg/day dose.

Unlabelled: The aim of the study was to evaluate the degree of membrane lipid peroxidation, internal microviscosity, activity of both total and Na+, K+ membrane ATP-ase and markers of oxidative damage of membrane protein in erythrocytes of elderly people with primary hypertension., Material and Methods: The examination was performed on 50 people. The first group (HA) consisted of 15 elderly people with primary hypertension (mean age 71, 3 years old). The reference groups were formed with healthy elderly people (K1) (15 people, mean age 72, 4 years old) and younger healthy people (K2) (20 people, mean age 55, 3 years old)., Results: Membrane lipid peroxidation of red blood cells was significantly increased in the group of elderly people with primary hypertension (HA). The lowest level of lipid peroxidation was observed in the (K2) normotensive group of younger people. Erythrocyte internal microviscosity was significantly higher in the group of healthy elderly people (K1) compared with the group of healthy younger people (K2). In HA group additional essential increase in microviscosity was observed in comparison with K1 and K2. The activity of both total and Na+, K+ membrane ATP-ase was significantly the highest in the group of younger people and the lowest in the group of elderly people with primary hypertension. In HA group increased damage of membrane protein was observed that was indicated by the reduced -SH group content and the increased value of W/S parameter in comparison with K1 and K2 groups., Conclusions: The obtained results indicate that in the elderly people with accompanying primary hypertension the whole-body oxidative stress is increased, which may be indicated by structural and functional oxidative damage of red blood cells. These observations may be significant in the pathogenesis of hypertension complications. This observation may be important in the pathogenesis of hypertension complications in this period of life.

Unlabelled: In recent studies it was observed the pleiotropic properties beyond hypolipemic effects of fenofibrate: anti-inflammatory, antioxidants effects, positive impact on glucose metabolism, thrombosis, fibrinolytic system endothelial dysfunction., The Aim of the Study: To estimate the effects of 4-weeks therapy of micronized fenofibrate in dose 267 mg/d on C-reactive protein (CRP), fibrinogen, thiobarbituric acid reaction substances (TBARS) concentrations in isolated erythrocyte membranes and the activities of antioxidants enzymes such: catalase (CAT), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) in erythrocytes in patients with visceral obesity and atherogenic dyslipidemia., Material and Methods: The study comprised 55 patients (pts), including 20 healthy volunteers and 35 pts with visceral obesity and dyslipidemia (TG>180 mg/dl, HDL-C < 40 mg/dl for men, <50 mg/dl for women) treated with micronized fenofibrate (267 mg/d). Before and after 4 weeks of active treatment the following parameters were determined: lipids (by enzymatic method using BioMerieux tests), CRP (by immunoturbidimetric method), fibrinogen (by Clauss'a method), TBARS concentrations (by method of Stock and Dormandy), CAT (method of Bartosz et al.), GSH-Px (method of Rice-Evansa), SOD (method of Misra) activities., Results: It was noticed significantly higher concentrations of CRP fibrinogen, TBARS and lower activities of CAT GSH-Px, SOD in patients with visceral obesity and atherogenic dyslipidemia than in the control group. The micronized fenofibrate caused a significant decrease in serum total cholesterol (by 15%), TG (by 38%), CRP (by 35%), fibrinogen (by 26%) and TBARS (by 33%) concentrations associated with a increase in CAT (by 35%), GSH-Px (by 63%), SOD (by 31%) activities., Conclusion: We conclude that micronized fenofibrate beyond hipolipemic efficacy demonstrates the antioxidative and anti-inflammatory properties in patients with visceral obesity and atherogenic dyslipidemia.

Unlabelled: The free radical theory of aging assumes that aging process leads to lost of oxidative balance. Oxidative stress induces structural and functional changes in red blood cell. The Q10 coenzyme is known as a compound which may partially prevent those changes in erythrocytes, due to its antioxidative properties and the important role it plays in the cell. The content of the coenzyme in human body decreases with age. The aim of the research was to evaluate the degree of membrane lipid peroxidation, internal microviscosity, activity of membrane ATP-ase and oxidative damage markers of erythrocyte membrane protein in elderly people before and after Q10 coenzyme therapy., Material and Methods: The examination was performed on 35 people. The examined group consisted of elderly people (older than 65 years old). The reference group was formed with people at the age between 51 and 59. In both groups the initial parameters of red blood cells were evaluated. In the elderly people the investigated parameters were also controlled after three and six weeks of Q10 coenzyme intake., Results: The Q10 coenzyme supplementation in elderly people produced the increase in the -SH group contents and reduction of W/S parameter. After supplementation of Q 10 coenzyme the decrease of lipid peroxidation products and internal microviscosity of erythrocytes and increase of the activity of membrane ATP-ase (total and Na+,K+) were observed., Conclusion: The obtained results may indicate the intensification of oxidative stress in elderly and point to beneficial effect of supplementation-metabolic therapy with Q10 coenzyme on structural and functional parameters of red blood cells in elderly people.

We studied the damage caused to erythrocyte membranes by chlorophenoxyacetic herbicides. An increase in haemolysis was observed. The compounds investigated caused lipid bilayer damage by lipid peroxidation, as well as an increase in membrane fluidity at the 16th carbon atom of fatty acids was observed. Metabolites caused damage to membrane proteins - the free SH group content was increased. Higher toxicity of metabolites compared to basic compounds was observed.